Erratum to Preventive strategies aimed at reducing the health risks of aflatoxin B1 (Toxicology and Environmental Health Sciences, (2012), 4, 2 (71-79), 10.1007/s13530-012-0119-4);Preventive strategies aimed at reducing the health risks of Aflatoxin B1

Toxicology and Environmental Health Sciences

Volumn 4, Issue 2, 2012, Pages 71-79

  Valencia Quintana, Rafael ^a   Sánchez Alarcón, Juana ^a   Tenorio, María Guadalupe ^a   Deng, Youjun ^a   Waliszewski, Stefan Marian ^a   Valera, Miguel Ángel ^a  

^a CENTRO TLAXCALA DE BIOLOGÍA DE LA CONDUCTA   (Mexico)

Author keywords

Aspergillus flavus; Chemoprevention; Chlorophyllin; DNA damage; Enterosorbents; Ethoxyquin; HCC risks; Isothiocyanates; Polyphenols

Indexed keywords

AFLATOXIN B1; BUTYLATED HYDROXYANISOLE; BUTYLCRESOL; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; ETHOXYQUIN; GLUTATHIONE TRANSFERASE; GREEN TEA EXTRACT; ISOTHIOCYANIC ACID; OLTIPRAZ; POLYPHENOL; PROBIOTIC AGENT; SULFORAPHANE;

CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTAMINATION; DNA DAMAGE; DNA FRAGMENTATION; EARLY INTERVENTION; GARLIC; GENOTOXICITY; HEALTH HAZARD; HEALTH IMPACT ASSESSMENT; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LIVER CELL CARCINOMA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREVENTIVE HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84873248107     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/s13530-012-0138-1     Document Type: Erratum

References (51)

1. Blount, W. P. Turkey, "X" disease. J. Br. Turkey Fed. 9, 55-58 (1961).
2. Kensler, T. W., Roebuck, B. D., Wogan, G. N. & Groopman, J. D. Aflatoxin: A 50-year odyssey of mechanistic and translational toxicology. Tox. Sci. 120, S28-S48 (2011).
3. Hendricks, J. D. Carcinogenicity of aflatoxins in nonmammalian organisms. in The Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance (eds Eaton, D. L. & Groopman, J. D.) 103-136 (Academic Press, New York, 1994).
4. 1 toxicity in human blood. Cytotechnology62, 157-165 (2010).
5. Groopman, J. D., Kensler, T. W. & Wild, C. P. Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu. Rev. Public. Health29, 187-203 (2008).
6. Phillips, T. D. Dietary clay in the chemoprevention of aflatoxin-induced disease. Tox. Sci. 52, 118-126 (1999).
7. Bennett, J. W. & Klich, M. Mycotoxins. Clin. Microbiol. Rev. 16, 497-516 (2003).
8. 1. Nutrition & Metabolism8, 1-16 (2011).
9. Sudakin, D. L. Dietary aflatoxin exposure and chemoprevention of cancer: a critical review. Clin. Tox. 41, 195-204 (2003).
10. Park, D. L. Effect of processing on aflatoxin. Adv. Exp. Med. Biol. 504, 173-179 (2002).
11. Simonich, M. T. et al. Natural chlorophyll inhibits aflatoxin B1 induced multi-organ carcinogenesis in the rat. Carcinogenesis28, 1294-1302 (2007).
12. Egner, P. et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Nat. Acad. Sci. 98, 14601-14606 (2001).
13. Jubert, C. et al. Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B1 pharmacokinetics in human volunteers. Cancer Prev. Res. 2, 1015-1022 (2009).
14. Fahey, J. W. et al. Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes. Carcinogenesis26, 1247-1255 (2005).
15. 1-8, 9-epoxide. Biochem. J. 279, 385-398 (1991).
16. Guyonned, D., Belloir, C., Suscheted, M., Siess, M. H. & Le Bon, A.-M. Mechanisms of protection against aflatoxin B1 genotoxicity in rats treated by organ sulfur compounds from garlic. Carcinogenesis23, 1335-1341 (2002).
17. Moyers, S. B. & Kumar, N. B. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nut. Rev. 62, 204-211 (2004).
18. Wu, H. C. et al. Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis28, 995-999 (2007).
19. Yang, C. S. et al. Molecular targets for the cancer preventive activity of tea polyphenols. Mol. Carcinog. 45, 431-435 (2006).
20. Luo, H. et al. Phase II a chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis27, 262-268 (2006).
21. Tang, L. et al. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis29, 411-417 (2008).
22. McLellan, L. I., Judah, D. J., Neal, G. E. & Hayes, J. D. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors. Biochem. J. 300, 117-124 (1994).
23. Roebuck, B. D., Liu Y. L., Rogers, A. E., Groopman J. D. & Kensler T. W. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyll-1, 2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res. 51, 5501-5506 (1991).
24. Bolton M. G. et al. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res. 53, 3499-3504 (1993).
25. Langouet, S. et al. Inhibition of human cytochrome P450 enzymes by 1, 2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Chem. Res. Toxicol. 13, 245-252 (2000).
26. Talalay, P., Dinkova-Kostova, A. T. & Holtzclaw, W. D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzyme Regul. 43, 121-134 (2003).
27. Fahey, J. W. & Kensler, T. W. Role of dietary supplements/nutraceuticals in chemoprevention through induction of cytoprotective enzymes. Chem. Res. Toxicol. 20, 572-576 (2007).
28. 1 genotype and CYP3A4 gene expression. Tox. Sci. 116, 422-432 (2010).
29. Fahey, J. W. et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl. Acad. Sci. U. S. A. 99, 7610-7615 (2002).
30. Dinkova-Kostova, A. T. et al. Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol. Biomarkers Prev. 16, 847-851 (2007).
31. Kensler, T. W. et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo Township, Qidong, People's Republic of china. Cancer Epidemiol. Biomarkers Prev. 14, 2605-2613 (2005).
32. Heber, D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J. Postgrad. Med. 50, 145-149 (2004).
33. Ramadan, M. F. & Morsel, J. T. Oil cactus pear (Opuntia ficus-indica). Food Chem. 82, 339-345 (2003).
34. Stintzing, F. C. & Carle, R. Cactus stems (Opuntia spp.): a review on their chemistry, technology, and uses. Mol. Nutr. Food Res. 49, 175-194 (2005).
35. Tesoriere, L., Fazzari, M., Allegra, M. & Livrea, M. A. Biothiols, taurine, and lipid soluble antioxidants in the edible pulp of Sicilian cactus pear (Opuntia ficusindica) fruits and changes of bioactive juice components upon industrial processing. J. Agric. Food Chem. 20, 7851-7855 (2005).
36. Shon, M. Y., Choi, S. D., Kahng, G. G., Nam, S. H. & Sung, N. J. Antimutagenic, antioxidant and free radical scavenging activity of ethyl acetate extracts from white, yellow and red onions. Food Chem. Toxicol. 42, 659-666 (2004).
37. Abdel-Wahahab, M. A. et al. Zizyphus spina christi extract protects against aflatoxin B1-initiated hepatic carcinogenicity. Afr. J. Trad. CAM4, 248-256 (2007).
38. Cavin, C., Holzhäuser, D., Constable, A., Huggett, A. C. & Schilter, B. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis19, 1369-1375 (1998).
39. 1. Rev. Cubana Aliment. Nutr. 11, 10-14 (1997).
40. Verma, R. J. & Nair, A. Vitamin E ameliorate aflatoxin-induced biochemical changes in the testis of mice. Asian J. Androl. 3, 305-309 (2008).
41. 1 and ochratoxin A. Toxins2, 738-757 (2010).
42. DeFlora, S. & Ferguson, I. R. Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 591, 8-15 (2005).
43. Yang, C.-F. et al. Inhibition of ebselen on aflatoxin B1-induced hepatocarcinogenesis in Fisher 344 rats. Carcinogenesis21, 2237-2243 (2000).
44. Mogilnaya, O. A., Puzyr, A. P., Baron, A. V. & Bondar, V. S. Hematological parameters and the state of liver cells of rats after oral administration of aflatoxin B1 alone and together with nanodiamonds. Nanoescale Res. Lett. 5, 908-912 (2010).
45. Phillips, T. D. et al. Reducing human exposure to aflatoxin through the use of clay: a review. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess25, 134-145 (2008).
46. Kannewischer, I., Tenorio, M. G., White, G. N. & Dixon, J. B. Smectite Clays as Adsorbents of Aflatoxin B1: Initial Steps. Clay Science, Japan. 12Suppl 2, 99-204 (2006).
47. Mulder, I., Barrientos, A. L., Tenorio, M. G., White, G. N. & Dixon J. B. Smectite clay sequestration of aflatoxin B1: particle size and morphology. Clays and Clay Minerals56, 558-570 (2008).
48. Tenorio, M. G., Mulder, I., Barrientos, A. L. & Dixon, J. B. Smectite clay adsorption of aflatoxin vs. octahedral composition and alteration history indicated by FTIR. Clays and Clay Minerals56, 571-578 (2008).
49. Strosnider, H. et al. Workgroup report: public health strategies for reducing aflatoxin exposure in developing countries. Environ. Health Perspect. 114, 1898-1903 (2006).
50. Liu, Y. & Wu, F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ. Health Perspect. 118, 818-824 (2010).
51. Turner, P. C. et al. Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int. J. Epidemiol. 36, 1119-1125 (2007).